[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 596
Citations 0
Capitol Health Call
May 10, 2016

Doubling Cap on Patients Physicians Can Treat With Buprenorphine

Author Affiliations

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(18):1938. doi:10.1001/jama.2016.4569

Sen Susan Collins (R, Me) praised a new proposed rule by the Department of Health and Human Services (HHS) that would increase the number of patients with opioid use disorders qualified physicians can treat with buprenorphine, a μ-opioid receptor partial agonist approved for clinical use by the Food and Drug Administration in 2002 (http://1.usa.gov/1XZUhq2).

Qualified physicians are those who have received a waiver from the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Agency to prescribe buprenorphine. In addition, they must possess subspecialty board certification in addiction medicine or addiction psychiatry or work in a qualified practice setting.